Outcome Study of Lanthanum Carbonate Compared With Calcium Carbonate on Cardiovascular Mortality and Morbidity in Patients With Chronic Kidney Disease on Hemodialysis (CKD5D)

Trial Profile

Outcome Study of Lanthanum Carbonate Compared With Calcium Carbonate on Cardiovascular Mortality and Morbidity in Patients With Chronic Kidney Disease on Hemodialysis (CKD5D)

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 25 Aug 2014

At a glance

  • Drugs Lanthanum carbonate (Primary) ; Calcium carbonate
  • Indications Hyperphosphataemia
  • Focus Adverse reactions
  • Acronyms LANDMARK
  • Most Recent Events

    • 25 Aug 2014 Last checked against ClinicalTrials.gov record.
    • 21 Aug 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 04 Dec 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top